ArticleCancer chemotherapy and pharmacology2012

Evaluating rational non-cross-resistant combination therapy in advanced clear cell renal cell carcinoma: combined mTOR and AKT inhibitor therapy.

William S Holland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.